updated recommendations for the management of rheumatoid arthritis (RA)
address treatment with conventional synthetic disease-modifying
antirheumatic drugs (csDMARDs), biologic DMARDs (bDMARDs), and targeted
synthetic DMARDs (tsDMARDs); glucocorticoids; and the use of these
medications in certain high-risk populations.
Find the latest ACR COVID-19 updates, including clinical guidance as well as practice and advocacy support.
Discover the ACR’s mobile resource for clinicians caring for patients with rheumatic diseases. The app has interactive tools and content to inform treatment decisions at the point of care. Available for iOS and Android devices.
The ACR practice management and quality resource area contains information to assist with improving the clinical and business aspects of your practice, including the latest information on practice management, clinical practice guidelines, insurance advocacy, and regulations.
Rheumatologists and rheumatology health professionals will also find resources to assist with revenue cycle management, coding and auditing, insurance advocacy, quality measurement, and much more.
Find rheumatology office support information on billing, coding, revenue cycle management, and practice flow to help you manage your rheumatology practice.
Administrative Support Resources
See information to support rheumatology clinical practice, including clinical practice guidelines, disease-specific criteria, quality measures, and much more.
Clinical Support Resources
Access members-only toolkits for transitioning patients with childhood-onset rheumatic diseases that persist into adulthood.
Pediatric to Adult Rheumatology Care Transition Toolkits
Learn about the Reproductive Health Initiative (RHI), a multi-disciplinary, multi-stakeholder initiative that is being designed and developed to assist with the dissemination and implementation of scientifically sound information to address the unmet needs in the treatment and management of fertility, pregnancy, and lactation in those affected by autoimmune and systemic inflammatory diseases.
Reproductive Health Initiative